✦ LIBER ✦

P1220 MODELING PREDICTS CLINICALLY MEANINGFUL SVR RATES IN GENOTYPE 1 TREATMENT-EXPERIENCED PATIENTS BASED ON RESULTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS TREATED WITH SOFOSBUVIR + PEGINTERFERON + RIBAVIRIN FOR 12 WEEKS

✍ Scribed by Muir, A.; Nelson, D.R.; Gordon, S.C.; Feld, J.J.; Patel, K.; Lawitz, E.; Sheikh, A.M.; Brainard, D.M.; Symonds, W.T.; McHutchison, J.G.; Bekele, B.N.; Mangia, A.; Gane, E.J.

Book ID: 122289599
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 56 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61380-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

996 TREATMENT WEEK 12 RESULTS OF WEIGHT-

996 TREATMENT WEEK 12 RESULTS OF WEIGHT-BASED TARIBAVIRIN VERSUS WEIGHT-BASED RIBAVIRIN, BOTH WITH PEGINTERFERON ALFA-2B, IN NAIVE CHRONIC HEPATITIS C, GENOTYPE 1 PATIENTS

✍ F. Poordad; E. Lawitz; E. Chun; J. Hammond 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

14 EFFICACY AND SAFETY OF WEIGHT-BASED R

14 EFFICACY AND SAFETY OF WEIGHT-BASED REGIMENS OF TARIBAVIRIN OR RIBAVIRIN, GIVEN WITH PEGINTERFERON ALFA-2B, AT 12 WEEKS AFTER TREATMENT (SVR12) IN NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC-HEPATITIS C

✍ F. Poordad; E. Lawitz; R. Pozza; M. Shiffman; B. Bacon; E. Godofsky; D. Halliman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

1421 HIGH SUSTAINED VIROLOGIC RESPONSE R

1421 HIGH SUSTAINED VIROLOGIC RESPONSE RATE IN TREATMENT-NAIVE HCV GENOTYPE 1A AND 1B PATIENTS TREATED FOR 12 WEEKS WITH AN INTERFERON-FREE ALL-ORAL QUAD REGIMEN: INTERIM RESULTS

✍ Sulkowski, M.; Rodriguez-Torres, M.; Lawitz, E.; Shiffman, M.; Pol, S.; Herring, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 109 KB